Atea Pharmaceuticals, Inc. (AVIR)
NASDAQ: AVIR · Real-Time Price · USD
4.040
-0.010 (-0.25%)
Oct 23, 2026, 4:00 PM EDT - Market closed
Atea Pharmaceuticals Market Cap
Atea Pharmaceuticals has a market cap or net worth of $324.03 million as of October 23, 2026. It is the 17,562nd most valuable company in the world and the 3,097th biggest in the United States. Its market cap has increased by 24.49% in one year.
Market Cap
324.03M
Enterprise Value
104.99M
1-Year Change
24.49%
Global Rank
Country Rank
#3,097 United States
Category
ChartMarket Cap Chart
Since the IPO on October 30, 2020, Atea Pharmaceuticals's market cap has decreased from $1.94B to $324.03M, a decrease of -83.28%. That is a compound annual growth rate of -25.84%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 324.03M | 16.18% |
| Dec 31, 2025 | 278.91M | -1.43% |
| Dec 31, 2024 | 282.95M | 11.19% |
| Dec 29, 2023 | 254.48M | -36.48% |
| Dec 30, 2022 | 400.61M | -46.08% |
| Dec 31, 2021 | 742.94M | -78.48% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 30, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Scribe Therapeutics | 363.87M |
| Capricor Therapeutics | 356.97M |
| Relmada Therapeutics | 350.41M |
| vTv Therapeutics | 350.15M |
| Nautilus Biotechnology | 347.41M |
| Opus Genetics | 345.68M |
| Orchestra BioMed Holdings | 345.00M |
| Galectin Therapeutics | 340.87M |